Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry

NCT04279496 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 35000

Last updated 2024-11-26

No results posted yet for this study

Summary

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

Conditions

Sponsors & Collaborators

  • Cleerly, Inc.

    lead INDUSTRY

Principal Investigators

  • James K Min, MD · Cleerly, Inc.

  • Todd Villines, MD · UVA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2027-06-01
Completion
2027-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04279496 on ClinicalTrials.gov